Idexo is an NFT platform for innovators, drastically reducing the time, cost, and complexity of creating major application innovations.
According to CryptoRank data, the second quarter of 2026 is on track to be the worst quarter for the ICO/IDO market in the past five years. Data shows that only $58 million was raised through IEOs, ICOs, and IDOs this quarter, a decline of 85% quarter-over-quarter. The number of public sales dropped from 105 in the first quarter to 37, a decrease of 65%. Notably, only 13 token sales were completed in May, the lowest monthly figure since December 2020 (which had 4 sales).In contrast, the first quarter of 2025 reached a cyclical peak, with 429 public sales raising nearly $849 million. Since then, momentum has continued to wane, with current fundraising amounts shrinking by more than 14 times from that peak. Analysts point out that investors are becoming more cautious, demand for new projects' public fundraising has significantly weakened, and token public sales are gradually losing their status as a mainstream fundraising vehicle.
According to Yu Jin’s monitoring, Bio Protocol recently launched a BIO staking-based IDO over the past two days, after which BIO surged by over 100%. Shortly after BIO’s rapid price increase, Bio Protocol’s multisig wallet transferred 80 million BIO tokens (approximately $5.15 million) to Binance and OKX eight hours ago.